potassium chloride has been researched along with bosentan anhydrous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amrani, M; Chester, AH; Goodwin, AT; Gray, CC; Yacoub, MH | 1 |
Dauzat, M; Obert, P; Reboul, C; Tanguy, S | 1 |
2 other study(ies) available for potassium chloride and bosentan anhydrous
Article | Year |
---|---|
Inhibition of endogenous endothelin during cardioplegia improves low coronary reflow following prolonged hypothermic arrest.
Topics: Animals; Bicarbonates; Bosentan; Calcium Chloride; Cardioplegic Solutions; Coronary Circulation; Endothelin Receptor Antagonists; Endothelin-1; Glycopeptides; Heart Arrest, Induced; Hypothermia, Induced; Magnesium; Male; Metalloendopeptidases; Myocardial Contraction; Myocardial Reperfusion Injury; Potassium Chloride; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sulfonamides; Time Factors | 1997 |
Chronic exercise does not prevent hypoxia-induced increased aortic sensitivity to endothelin in rats.
Topics: Animals; Aorta, Thoracic; Bosentan; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Hypoxia; Male; Physical Conditioning, Animal; Potassium Chloride; Rats; Receptor, Endothelin A; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents | 2006 |